Abstract:
Glioblastoma multiforme (GBM) is the most common aggressive malignant primary brain tumor, afflicting approximately 3 in every 100,000 persons in the United States, with an incidence rate that is 1.6 times higher in males compared to females. Arising from the neural and/or glial progenitor/stem cells, GBM is commonly located in the supratentorial cortical region affecting the frontal lobes. The rapid local growth and spread of GBM leads to a dismal prognosis with a 5-year survival rate of 6.9%, despite multiple therapeutic interventions, including surgery, radiotherapy, and chemotherapy. To overcome the challenge to develop curative treatments of GBM, several promising experimental methods (gene therapy, immune therapy, oncolytic viral therapy, and simulated microgravity therapy) are under investigation. Potentially beneficial effects of microgravity on GBM include (A) the repression of survival signaling pathways, (B) the induction of the apoptosis of cancerous cells, and (C) the blocking of spherical colony formation and cellular proliferation via the downregulation of ataxia telangiectasia mutated/ataxia telangiectasia and Rad3-related (ATM/ATR) and cyclin-dependent kinase 1/2 (CDK1/2) proteins to block cellular phase 2 to progress to G2. Our hypothesized combination of oncolytic viral therapy using an autonomous rat parvovirus H1 with simulated microgravity utilizing the potentially beneficial effects of microgravity on tumor cells (decreased cell proliferation, disrupted mitochondrial functions, and the induction of apoptosis) [1] was limited using simulated microgravity on earth. We now propose to conduct similar investigations on space stations where gravity approaches zero. We hypothesize that oncolytic viral therapy in space without gravity will (A) lyse tumor cells through the induction of apoptosis, decreased cell proliferation, and the induction of an immune response, and (B) constitute the foundation of potentially curative treatments of GBM.
Supplementary Materials
The following are available online at https://www.mdpi.com/article/10.3390/proceedings2024100024/s1.
Author Contributions
Conceptualization, T.E. and J.R.B.; methodology, T.E. and J.R.B.; software, T.E.; validation, T.E. and J.R.B.; formal analysis, T.E.; investigation, T.E.; resources, T.E. and J.R.B.; data curation, T.E. and J.R.B.; writing—original draft preparation, T.E.; writing—review and editing, T.E. and J.R.B.; visualization, T.E. and J.R.B.; supervision, T.E. and J.R.B.; project administration, T.E. and J.R.B.; funding acquisition, T.E. All authors have read and agreed to the published version of the manuscript.
Funding
This research received no external funding.
Institutional Review Board Statement
Not applicable.
Informed Consent Statement
Not applicable.
Data Availability Statement
All data is included in this article.
Conflicts of Interest
The authors declare no conflict of interest.
Reference
- Elshourbagy, T.; Brašić, J.R. Amelioration of glioblastoma multiforme via the combination of simulated microgravity and oncolytic viral therapy. Med. Sci. Forum 2023, 20, 9. [Google Scholar] [CrossRef] [Scilit]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).